Vanberra Signal

DeepLife

Curated by Signal

Provider of AI-based drug discovery and omics analysis tool for researchers

Overview

Provider of AI-based drug discovery and omics analysis tool for researchers. The company has developed tools that are AI-enabled for the process of drug discovery. The tool assists in provided insights for target protein for the drug for an individual patient. The tools use machine learning technology to identify molecular triggers for the drug and target identification. It has features to process biological data, tools for genomic screening, and more.

Key facts

Founded
2019
Headquarters
Paris, France

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Online personal health data aggregation and recommendations platform

    Health TechnologyParis, France
  • Mobile-based application for fitness training

    Health TechnologyParis, France
  • Provider of AI-based device for monitoring cardiology health

    Health TechnologyBesancon, France

About DeepLife

What does DeepLife do?

Provider of AI-based drug discovery and omics analysis tool for researchers.

Where is DeepLife headquartered?

DeepLife is headquartered in Paris, France.

When was DeepLife founded?

DeepLife was founded in 2019.

Which sector is DeepLife in?

DeepLife operates in Health Technology.

Who are DeepLife's competitors?

Companies similar to DeepLife include Umanlife, NOERDEN, and Archeon Medical.